Prosus Valuation

Is PRXA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PRXA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PRXA (€38.03) is trading above our estimate of fair value (€25.81)

Significantly Below Fair Value: PRXA is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for PRXA?

Key metric: As PRXA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PRXA. This is calculated by dividing PRXA's market cap by their current earnings.
What is PRXA's PE Ratio?
PE Ratio13.7x
EarningsUS$6.88b
Market CapUS$94.14b

Price to Earnings Ratio vs Peers

How does PRXA's PE Ratio compare to its peers?

The above table shows the PE ratio for PRXA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average16.9x
NXT NEXT
14.4x2.6%UK£11.6b
BME B&M European Value Retail
10.7x11.1%UK£3.5b
JD JD.com
10.4x8.2%US$50.3b
WES Wesfarmers
32.1x8.2%AU$80.5b
PRXA Prosus
13.7x4.8%€90.4b

Price-To-Earnings vs Peers: PRXA is good value based on its Price-To-Earnings Ratio (13.7x) compared to the peer average (16.7x).


Price to Earnings Ratio vs Industry

How does PRXA's PE Ratio compare vs other companies in the Global Multiline Retail Industry?

6 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies20PE01632486480+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PRXA is good value based on its Price-To-Earnings Ratio (13.7x) compared to the Global Multiline Retail industry average (19.8x).


Price to Earnings Ratio vs Fair Ratio

What is PRXA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PRXA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.7x
Fair PE Ratio24.9x

Price-To-Earnings vs Fair Ratio: PRXA is good value based on its Price-To-Earnings Ratio (13.7x) compared to the estimated Fair Price-To-Earnings Ratio (24.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PRXA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€38.03
€47.41
+24.7%
15.2%€65.03€37.00n/a17
Nov ’25€39.31
€46.46
+18.2%
16.3%€65.03€36.00n/a17
Oct ’25€39.65
€44.34
+11.8%
11.4%€54.86€36.00n/a17
Sep ’25€33.65
€44.34
+31.8%
11.4%€54.86€36.00n/a17
Aug ’25€32.24
€43.76
+35.8%
12.4%€54.86€34.00n/a18
Jul ’25€33.06
€43.12
+30.4%
13.7%€54.86€33.00n/a18
Jun ’25€33.20
€42.69
+28.6%
13.6%€52.00€33.00n/a18
May ’25€31.84
€42.83
+34.5%
20.9%€74.00€33.00n/a17
Apr ’25€29.05
€42.23
+45.3%
21.4%€74.00€32.00n/a18
Mar ’25€27.15
€42.62
+57.0%
21.7%€74.00€32.00n/a18
Feb ’25€27.82
€42.45
+52.6%
21.6%€74.00€32.00n/a18
Jan ’25€26.79
€43.22
+61.4%
21.5%€74.00€32.00n/a17
Dec ’24€30.34
€43.19
+42.4%
21.5%€74.00€32.00n/a17
Nov ’24€26.76
€41.25
+54.1%
13.1%€49.40€32.00€39.3116
Oct ’24€27.74
€41.00
+47.8%
13.2%€49.40€32.00€39.6516
Sep ’24€28.74
€41.76
+45.3%
12.9%€50.47€33.03€33.6517
Aug ’24€33.11
€41.42
+25.1%
12.6%€50.47€33.03€32.2417
Jul ’24€30.69
€40.77
+32.8%
13.3%€50.47€32.12€33.0618
Jun ’24€28.93
€40.49
+40.0%
13.0%€48.63€30.74€33.2019
May ’24€31.11
€40.51
+30.2%
13.3%€49.55€30.74€31.8419
Apr ’24€33.02
€40.55
+22.8%
14.3%€49.55€29.82€29.0518
Mar ’24€32.53
€40.52
+24.6%
13.6%€49.55€29.82€27.1520
Feb ’24€33.91
€39.73
+17.2%
13.8%€49.55€29.82€27.8220
Jan ’24€30.10
€38.62
+28.3%
12.8%€48.63€29.82€26.7919
Dec ’23€28.33
€37.39
+32.0%
13.4%€47.72€29.82€30.3419
Nov ’23€21.83
€39.81
+82.3%
15.7%€50.47€28.45€26.7619

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies